Patient-reported outcomes of cemiplimab versus chemotherapy in advanced NSCLC: PD-L1 level subgroups in EMPOWER-lung 1

Basit Öğe Kaydı
dc.authoridSaadettin Kılıçkap / 0000-0003-1637-7390
dc.authorscopusidSaadettin Kılıçkap / 8665552100
dc.authorwosidSaadettin Kılıçkap / FBU-6263-2022en_US
dc.contributor.authorSezer, Ahmet
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorBondarenko, Igor N
dc.contributor.authorÖzgüroğlu, Mustafa
dc.contributor.authorGogishvili, Miranda
dc.contributor.authorHe, X.
dc.contributor.authorGullo, Guiseppe
dc.contributor.authorRietschel, Petra
dc.contributor.authorQuek, Ruben Gw
dc.date.accessioned2022-11-13T19:34:16Z
dc.date.available2022-11-13T19:34:16Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractPatient-reported outcomes of cemiplimab versus chemotherapy in advanced NSCLC: PD-L1 level subgroups in empower-lung 1en_US
dc.identifier.citationKilickap, S., Sezer, A., Gumus, M., Bondarenko, I., Ozguroglu, M., Gogishvili, M., ... & Quek, R. G. (2022). Patient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1.en_US
dc.identifier.endpage126en_US
dc.identifier.issn1556-0864en_US
dc.identifier.issn1556-1380en_US
dc.identifier.issue9en_US
dc.identifier.startpage125en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12713/3375
dc.identifier.volume17en_US
dc.identifier.wosWOS:000858678100196en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorKılıçkap, Saadettin
dc.language.isoenen_US
dc.publisherElsevier Scienceen_US
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNon-Small Cell Lung Canceren_US
dc.subjectPatient-Reported Outcomesen_US
dc.subjectCemiplimaben_US
dc.titlePatient-reported outcomes of cemiplimab versus chemotherapy in advanced NSCLC: PD-L1 level subgroups in EMPOWER-lung 1en_US
dc.typeConference Objecten_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu